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The Lm-1  locus controls the expression of one or more cell surface alloantigens 
recognized by cytotoxic T  lymphocytes (CTL). ~ Earlier studies showed Lm-1  is 
Igh-linked  and located five map units telomeric to Pre-I  on chromosome 12 (1). 
Two  Lm-1  alleles  (Lm-1 a  and  Lm-1 b)  were  identified,  and  lipopolysaccharide 
(LPS) blasts from 46 strains derived from crosses between Lm-I a and Lm-1 b mice 
were typed.  37  of these strains were known to have genetic recombinations in 
the telomeric region  of chromosome  12.  None of the recombinations  divided 
the Lm-1  locus;  i.e., all  strains  typed unambiguously as either Lm-I a or Lm-I b. 
Accordingly, if Lm-I  were to consist of more than one gene, such genes would 
have to be closely linked. 
Two other laboratories (2,  3)  have identified Igh-linked  loci for cell surface 
alloantigens recognized by CTL. Forman et al. (2) have defined a locus telomeric 
to Igh and Tsu that codes for an antigen (H-40) that is expressed only on surface 
Ig-positive  B  cells.  The  antigen  described  by  Rolink  et  ai.  (3),  H(C.),  is  also 
encoded by a  locus teiomeric to Igh,  but is expressed on both B and T  lympho- 
cytes. 
All of the above findings clearly demonstrate that the telomeric end of mouse 
chromosome 12 codes for cell surface determinants that are immunogenic for T 
cells. What is not clear, however, is the number of such antigens, their distribution 
and relationship to each other, and their possible role in cell differentiation and 
interaction. 
To elucidate further the nature of Lm-1  and its product(s), we tested different 
cell  types  for  expression  of  Lm-1  determinants.  We  show  here  that  Lm-1 
determinants (a) are expressed on T  and B cell blasts, some pre-B cell lines, and 
macrophages,  but  not  on  fibroblasts,  normal  (unstimulated)  thymocytes,  and 
cloned lines of two thymic T  cell lymphomas; (b) are differentially expressed on 
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T,  B  and pre-B cells; and  (c) may serve as important  histocompatibility  antigens 
for bone marrow  transplantation. 
Materials  and  Methods 
Mouse Strains 
BALB/cAnNIcr and C57BL/6NIcr are maintained  in the Laborator~ Animal Facility 
at the Institute for Cancer Research, Fox Chase Cancer Center. The Igh  congenic mouse 
strains C.B-17,  C.B-26,  C.B-31,  and C.B-39 have been described in detail previously (1). 
The  AXC-11,  CB-AL/1,  and  CXAXCB-2  strains  were  a  gift  from  Dr.  R.  Riblet,  Fox 
Chase Cancer Center, and were typed in the initial study (1). 
Cell Lines 
Abelson murine leukemia virus (A-MuL V)-induced pre-B cell lines.  A-MuLV-induced lines 
were  obtained  from  R.  Phillips  (Ontario  Cancer  Institute,  Toronto,  Canada).  Those 
derived from in vitro transformation of C.B-17 bone marrow include C.BAbl-7, C.BAbl- 
11,  C.BAbI-15,  C.BAbl-17,  and  C.BAbl-7853.  The lines, SAbl-11,  SAbl-12, and  SAbl-3 
were derived  from bone marrow of C.B-17scid mice (11).  All cell lines show rearrange- 
ments at both Igh alleles (I. J. Weiler, M.J. Bosma, R. Phillips, and R. Perry, unpublished 
results),  and,  where  tested,  react with monoclonal antibodies (12,  13) specific for pre-B 
and B cell determinants,  but lack surface Ig (our unpublished  results). 
T cell lines.  SCID 1-12  2H4 and  SCID 56  3B5 are cloned  cell lines derived  from T 
cell lymphomas (Thy-1.2 +, Lyt-1 +, Lyt-2  +) that arose in C.B-17scid mice (11). Both clones 
show gene rearrangement  at the/32 locus for the T  cell antigen  receptor, as revealed by 
Southern blot analysis using a ~  probe from T. Mak, Ontario Cancer Institute, Toronto 
(I. J. Weiler, personal communication). 
Immunizations 
CTL used in this study were generated by immunizing mice with spleen cells from their 
Lm-l-congenic partner strains. C.B-17 and C.B-26 express Lm-1 b, while C.B-31 and C.B- 
39 express Lm-1 ~. We have previously (1) shown that C.B-17 and C.B-26 differ from C.B- 
3 t  and C.B-39 at a segment of chromosome  12 that includes the Pre-I and Lm-I loci, but 
not the centromeric Igh or the telomeric Ly7 loci. We refer to CTL generated in C.B-17 
or C.B-26  mice against C.B-31  or C.B-39  spleen  cells as anti-Lm-l" effectors, and CTL 
generated in C.B-31  or C.B-39 mice against C.B-I 7 or C.B-26 spleen cells as anti-Lm-1 b 
effectors. 
Spleen  cells were  suspended  in  Hank's balanced  salt  solution  (HBSS),  emulsified  in 
complete Freunds adjuvant (CFA), and injected intraperitoneally (1/5 spleen per mouse) 
into  congenic  mice.  2  wk  later,  immunized  mice  were  boosted  with  the  same dose  of 
spleen cells in HBSS (without CFA), rested for 2 too, then boosted again with spleen cells 
in  HBSS at  monthly intervals.  There  was a  2-wk period between  the last immunization 
and sacrifice. We did not detect anti-Lm-t  antibodies in any mice, even after prolonged 
immunization. 
Generation of Cytotoxic Effector Cells 
Following  procedures  described  previously (4),  single-cell  suspensions  were prepared 
from spleens of immunized  mice (for anti-Era-1  effectors) or normal C57BL/6  mice (for 
anti-H-2  a effectors), and from spleens of the immunizing strain (stimulator cells). Eryth- 
rocytes were lysed by treatment with NH4Cl (5). Effector cells (at 5  x  106 cells/ml) were 
mixed with  equal  volumes of cesium-irradiated  stimulator  cells (2,000  rad),  also at 5  x 
10 ~ cells/ml, in Costar 3075  tissue culture flasks (16 ml/flask), and cultured  for 6 d  in a 
37°C humidified incubator.  The culture medium consisted of RPMI  1640 (Microbiolog- 
ical Associates, Walkersville,  MD),  10% fetal calf serum (Microbiological Associates), 5 x 
10 -5 M  2-mercaptoetbanol,  50  ug/ml  gentamycin  (Schering Corp.,  Union,  NJ),  10 mM 
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Preparation of Target Cells and Splenic LPS Blasts 
Cell suspensions of normal spleen  cells (erythrocytes lysed by NH4CI treatment)  were 
cultured at 5  x  10  ~ cells/ml  10 #g/ml with S. typhosa LPS, W  (Difco Laboratories,  Inc., 
Detroit,  MI) for 3 d  before labeling with  5JCr.  Where T  cell depletion  is indicated,  the 
adherent fraction from a  nylon wool column (6), was recovered by adding cold medium 
and compressing the column with a syringe plunger. 
Splenic T Cell Blasts 
Spleen  ceils  were  fractionated  by nylon  wool  filtration  according to  the  method  of 
Julius et al. (6).  The effluent fraction was cultured at 5  X  106 cells/ml with 5 ttg/ml Con 
A  (E. Y.  Laboratories, San  Mateo, CA) in Costar 3075 tissue culture flasks for 2-3 d  at 
37°C before use as targets. 
Thymocyte Blasts 
Thymocytes were cultured at 5 x  106 cell/ml in medium containing 50% supernatant 
ofconcanavalin A (Con A)-stimulated spleen ceils (Con A SN)at 37°C for 3 d before ~Cr 
labeling as described  above.  Con A  SN was prepared  by harvesting the supernatant  of 
Con A activated mouse spleen cells after 48 h in culture as described previously (7). 
Fibroblast Targets 
Fibroblast cultures were derived from explants from the subcutaneous connective tissue 
of 3-mo-old BALB/c and C.B-17 mice. Explants were originally cultured in 60-mm petri 
dishes  (Falcon  Labware,  Oxnard,  CA)  under  drops  of RPMI  media  supplemented  as 
described above. After 24 h, media (3 ml) was added to dishes, and the cultures were fed 
every  4  d.  After  2  wk,  fibroblasts  were  harvested  by  incubation  with  trypsin  EDTA 
solution (Gibco, Grand Island, NY) and passed into Costar 3075 culture flasks. Cells were 
passaged when grown to monolayers, and used as targets from I  to !.5 mo after culture 
initiation. 
Macrophage Targets 
Mice received  an  intraperitoneal  injection  of 2  ml  3%  thioglycollate medium  (Difco 
Laboratories) 4 d before sacrifice. Peritoneal cells were harvested by lavage and plated in 
flat-bottom  96-well  culture  plates  (Costar  3596)  at  l0 b cells/200  #l/well.  Cells  were 
incubated overnight and washed once before use as targets. 
Measurement of  Macrophage Death 
Following the  methods  of Parish  and  Mullbacher  (9),  macrophage  monolayers were 
overlaid with the various concentrations of effector cells. After a 6-h incubation, the plates 
were washed once with HBSS. The number of live macrophages remaining adherent was 
quantitated  by measuring  the  uptake  of neutral  red.  To  each  well,  200  #1 of 0.036% 
neutral red (Polysciences, Inc., Warrington,  PA) was added. Plates were placed at 37°C 
for  15  min.  The  neutral  red  solution  was  decanted,  and  the  wells  were  washed  by 
submerging the plates three times in phosphate-buffered saline, and inverting the plates 
on  paper  towels  between  each  wash.  The  macrophages  were  then  solubilized  by  the 
addition of 200 t~l of 0.5% sodium dodecyl sulfate in 0.05 M acetic acid to each well. The 
neutral  red released  from the  macrophages was quantitated  by measurement  of optical 
density (OD) by a micro-ELISA (enzyme-linked immunosorbent assay) autoreader MR580 
(Dynatech  Laboratories,  Alexandria,  VA) with  test  wavelength  540  nm  and  reference 
wavelength 630 nm.  Percent specific lysis (SL) was calculated as  100 x  (control -  test)/ 
control, where control =  OD with no effector cells present, and test =  OD with effector 
cells present. 
In this assay, both lysis and detachment of adherent macrophages caused by antigen- 
specific effector cells were scored as cell death.  While detached  macrophages are func- 
tionally compromised, they may not yet be lysed. However, as the amount of neutral red 
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specific effector  cells,  we  consider  this  assay  a  valid  and  reliable  way  to detect  Lm-1 
determinants on macrophages. The results were recorded as percent SL. 
5~Cr Labelling of Targets 
Cells were suspended in 100 ul of fetal calf serum (FCS) and  100 gCi Na251CrO4  (New 
England  Nuclear,  Boston,  MA),  and  incubated  at  37°C  for  1 h.  The  cells  were  then 
washed  three  times  to remove  free  isotope.  Targets  were suspended  at  10  ~ cell/ml  in 
RPMI  1640  with  20%  FCS,  and  100  #l/well  were assayed for lysis  in  the  cytotoxicity 
assay. 
5~Cr-release Assay 
After 6 d  in culture,  the effector cells were harvested and tested  in a  standard  51Cr- 
release  assay (8).  All results  are  reported  as percent  SL,  which is  calculated as  100  × 
(experimental  release -  spontaneous release)/(maximum  release -  spontaneous release), 
where experimental release is cpm 5~Cr released in the presence of effector cells. Maximum 
release  is  determined  by  detergent  lysis.  All  values  reported  represent  the  mean  of 
quadruplicate measurements.  In all cases, the SE was <5% and is, therefore, not given. 
For each experiment  shown, four fivefold dilutions of effectors were tested against a 
fixed number of targets. The starting effector/target ratio (E:T) was between  100:1 and 
50:1.  Except  for  cold-target  inhibition  experiments,  (see  below)  data  are  reported  as 
percent SL at the highest E:T ratio only. This ratio was chosen to demonstrate that, even 
at the highest E:T ratio, the targets that we have designated as negative for lysis are truly 
negative. However, when a given target is susceptible to lysis, the percent SL at the lowest 
E:T ratio was usually at least 50% that seen at the highest E:T ratio. The E:T ratio used 
to obtain the given values are noted in the table. 
Cold-target Inhibition of Anti-Lm-1  Effector Cells 
Effector cell lysis of labeled  target cells was inhibited  by addition of unlabeled target 
cells.  Effector cell  cultures  were  sampled  on the  fifth  day, and  the  cells  were  titrated 
against a fixed number of labeled target cells to determine limiting effector/labeled target 
ceil ratios (E:T'); i.e., the smallest ratio still  to give significant lysis of labeled targets.  In 
different experiments, limiting E:T' ratios ranged from 5:1 to 0.15:1, and they are noted 
in the legends. On the sixth day of culture,  effector cells were harvested for cold-target 
inhibition assays (14). Varying numbers of unlabeled target cells were added at limiting 
E:T' ratios. The ratio of unlabeled/labeled  target cells (T:T') is indicated in the figures. 
The  procedure  for each  assay was as  follows.  Effector cells  (100  #1)  were added  to 
microtiter wells, followed by unlabeled target cells (50 #1). Labeled target cells (also in 50 
#1) were added  last.  The cells were gently pelleted  by centrifugation for 4  rain  at  300 
rpm,  and  incubated  for  3-4  h.  Percent  inhibition  of lysis  by unlabeled  target  cells  is 
calculated  as  100  X  [1  -  (percent  SL with  added  T)/(percent  SL with  no added  T)]. 
Percent SL is given as the mean of quadruplicate determinations for each indicated T:T' 
ratio. In all experiments shown, the SE was <3%, and therefore is not given. 
Fluorescence-activated Cell Sorter (FACS) Analysis 
Cells  were  labeled  with  an  optimal  amount  of  fluorescein  isothiocyanate  (FITC)- 
conjugated  monoclonal rat  anti-Thy-l.2  antibody (10),  or  FITC-conjugated goat anti- 
mouse (Fab)2  sera (Cappel  Laboratories,  Cochranville,  PA). All unreacted antibody was 
removed by washing, and the cells were analyzed with a FACS II system (Becton Dickinson 
and Company, Sunnyvale, CA), using 488 nm laser illumination. 
In Vivo Cell Transfers 
One day before cell transfer, recipient mice received 600 tad irradiation from a X-ray 
source under the following conditions: 225 kV; filtration  1 mm AI and 0.5 mm Cu; dose 
rate 35-40 rad/min.  Mice were injected intravenously with 0.5 ml HBSS containing 107 
spleen cells and 2  x  106 bone marrow cells. At various times thereafter,  they were bled, 
and the sera were tested for Igh allotype markers. O'TOOLE  ET  AL.  611 
Antiallotype Assay 
The  expression  of  Igh  allotypes was  assayed  by  means  of immunoprecipitation  in 
Ouchterlony microplates. The preparation of these antisera and their specificity has been 
described previously (15). 
Results 
Expression  of Lm-1  Determinants on Splenic  T  Cell Blasts and Activated  Thymo- 
cytes.  51Cr targets were  prepared  from  splenic T  cell blasts, fresh  thymocytes, 
and thymocytes after  1,  2, and  3  d  of in vitro culture with Con A  SN.  Splenic B 
cell blasts were included as controls. Targets were tested for susceptibility to lysis 
by both  anti-Lm-1  effectors  and  anti-H-2  d  effectors.  All targets  were  lysed by 
anti-H-2  d effectors  (Table  I).  Anti-Lm-1 a effectors  killed both  splenic T  and  B 
cell blasts from  the Lm-1 a strain, C.B-31  (Table I). Target  cells from  the Lm-1 b 
strain, C.B-26,  were unaffected.  In the reciprocal experiment,  anti-Lm-I b effec- 
tors killed splenic T  and  B  cell blasts from  C.B-26  but not from  C.B-31.  Fresh 
thymocytes  and  thymocytes  after  1  d  in  culture  with  Con  A  SN  were  not 
susceptible to lysis by anti-Lm-1  effectors. When  cultured for 2-3  d  with Con A 
SN,  however,  thymocytes become  susceptible to  lysis (Table  I). Activation with 
Con  A  SN,  therefore,  results  in  the  conversion  of thymocytes  from  Lm-l-  to 
Lm-1 +. 
Two Independent Cultured Lines of Thymic T Cell Lymphomas Do Not Express Lm- 
1 Determinants.  The  cloned  T  cell lymphomas,  SCID  56  3B5  and  SCID  1-12 
TABLE  I 
Expression of Lm-1 Determinants on Thymic and Splenic T Cell Blasts 
Target  Target cell type  Target acti- 
strain  vator 
Time in  SL with various effectors: 
culture 
with activa-  Anti_Lm_l b  Anti-Lm-P  Anti-H-2  a 
tot 
d 
C.B-26  Splenic B cells*  LPS  3  62  1  75 
C.B-26  Splenic T cells*  Con A  3  39  0  72 
C.B-26  Thymocytes  Con A SN  0  0  0  40 
C.B-26  Thymocytes  Con A SN  1  0  0  45 
C.B-26  Thymocytes  Con A SN  2  25  0  65 
C.B-26  Thymocytes  Con A SN  3  57  0  60 
C.B-31  Splenic B cells  LPS  3  0  79  81 
C.B-31  Splenic T cells*  Con A  3  0  41  69 
C.B-31  Thymocytes  Con A SN  0  0  0  51 
C.B-31  Thymocytes  Con A SN  1  0  42  60 
C.B-31  Thymocytes  Con A SN  3  0  42  60 
All values obtained with E:T =  100:1. 
* B cells were prepared by culturing the nylon wool-adherent fraction of spleen cells with  LPS for 
3 d before use as targets. These cells were 92% surface lg-positive by FACS analysis. 
* T  cells were  prepared from  the  nylon  wool-effluent fraction of a  spleen cell suspension,  and 
cultured with  Con  A  for  3  d  before use as targets. These cells were 95%  Thy-l.2  + by FACS 
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TABLE II 
Thymic T Cell Lymphomas of C.B-17scid Do Not Express Lm-1 
Determinants 
In vitro stimula-  Target  Target cell type 
tor  source 
SL with effectors: 
Anti-  Anti.H.2d, 
Lm.lb* 
C.B-17  C.B-17  LPS blasts  42  62 
C.B-I 7  BALB/c  LPS blasts  0  59 
C.B-17  C.B-17scid  SCID-56  3B5  2  34 
C.B-17  C.B-17scid  SC1DI-122H4  0  36 
SCID 1-12 2H4  C.B-17  LPS blasts  0  64 
SCID 56 3B5  C.B-17  LPS blasts  0  62 
*  E:T=50:l. 
* E:T =  25:1. 
2H4,  were both tested for Lm-1  expression.  Neither cell line could stimulate, 
nor be lysed by, anti-Lm-1 b effectors (Table II). Controls show that both T  cell 
clones could stimulate and be  lysed by anti-H-2  ~ effectors. We consider these 
clones (Thy-l.2  +,  Lyt-1 ÷,  Lyt-2  +) examples of immature T  cells,  as they were 
derived from two  independent thymic T  cell  lymphomas of C.B-17scid  mice. 
These mice lack functional T  cells (11). 
Variable  Expression  of Lm-1  Determinants  on  Pre-B  Cell  Lines  Induced  by  A- 
MuLV.  A number of A-MuLV-induced cell lines of early B cell phenotype were 
tested for susceptibility to lysis by anti-Lm-1 effectors. With respect to cell lines 
of C.B-17  origin,  C.BAbl-7853,  C.BAbI-11,  and  C.BAbl-15  expressed  Lm-1 
determinants, and lines C.BAbI-17  and C.BAbl-7  did not.  Of the cell  lines of 
C.B-17scid  origin,  SAbI-11  and  SAbl-12  were  Lm-1 +,  and  SAbl-3  was  Lm-1- 
(Table III). All targets were susceptible to lysis by anti-H-2  d effectors. 
Expression of Lm-1 Determinants on Macrophages but Not on Fibroblasts.  Anti- 
Lm-I ~' and anti-Lm-1 b effectors were tested for the ability to kill  macrophages 
from both  LM-1 a and Lm-1 b strains.  Anti-L/n-l" effectors killed macrophages 
from the Lm-1 a strains,  BALB/c, C.B-39, and C.B-31  but not from the Lm-1 b 
strains,  C.B-17  and C.B-26  (Table  IV).  Conversely, anti-Lm-1 b effectors lysed 
macrophages from C.B-17,  C.B-26  (Table  IV), and C.B-17scid  mice (data  not 
shown). The results shown in  Table  IV  on  Lm-1  expression by macrophages 
were obtained using the neutral red assay described in Materials and Methods. 
This assay was chosen to demonstrate clearly the phagocytic ability of the target 
cell. However, these results have been repeated using a conventional 5~Cr release 
assay with  labeled,  thioglycollate-induced, peritoneal adherent cells  as  targets 
(data not shown). 
Fibroblast lines derived from the Lm-1 ~ and Lm-1 b strains were also tested for 
susceptibility to lysis. As shown in Table IV, these lines were lysed by anti-H-2  a 
effector cells but not by anti-Lm-1 effectors cells.  Not shown is that fibroblasts 
were  unable  to substitute for spleen  cells as  in  vitro stimulators of anti-Lm-1 
effectors. Further evidence that fibroblasts do not express  Lm-1  determinants O'TOOLE  ET  AL. 
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Cell Lines 
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SL with effectors: 
Target  Cell type 
strain origin  Anti-  Anti- 
Lm-l~*  Lm-l~* 
Anti-H-2  d* 
7~ 
C.B-31  LPS blasts  1  47  47 
C.B-26  LPS blasts  62  0  58 
C.B-17  C.BAbl-7853  42  0  58 
C.B-17  C.BAbI-11  13  0  Not done 
C.B-17  C.BAbI-I 5  11  0  40 
C.B-17  C.BAbI-17  0  0  60 
C.B-17  C.BAbl-7  0  0  45 
C.B-17scid  SAbI-11  33  0  45 
C.B-17scid  SAbI-12  32  0  27 
C.B-17scid  SAbl-3  0  0  57 
*  E:T  =  80:1. 
* E:T =  100:1. 
TABLE  IV 
Expression of Lm-1 Determinants on Macrophages but Not on 
Fibroblasts 
Target strain  Target cell type 
SL with effectors: 
Anti-  Anti-  Anti.H_2  d 
Lm-1  b  Lm-1  • 
C.B-17  Macrophages  47  0  48 
C.B- 17  Fibroblasts  4  0  91 
Splenic LPS blasts  75  0  89 
C.B-26 
BALB/c 
C.B-31 
C.B-39 
Macrophages  38  0  75 
Splenic LPS blasts  52  0  74 
Macrophages  0  54  70 
Fibroblasts  0  0  80 
Splenic LPS blasts  0  62  76 
Macrophages  0  49  56 
Splenic LPS blasts  0  62  85 
Macrophages  0  48  60 
Splenic LPS blasts  0  69  88 
All values obtained with E:T =  100:1. 614  Lm-1  EXPRESSION  AND  INCOMPATIBILITY 
comes from cold-target inhibition studies. BALB/c fibroblasts did not inhibit the 
killing of BALB/c LPS blasts by anti-Lm-1 ~ effectors, but did inhibit killing by 
anti-H-2  a effectors (data not shown). 
A  Common  Lm-1  Determinant  on  T  and  B  Cells  that Is Not Expressed  on  Pre-B 
Cells.  The ability of thymocyte blasts and splenic B cell blasts to inhibit the lysis 
of labeled thymocyte blasts is shown in Fig.  1.  Both sources of unlabeled blasts 
inhibited  anti-Lm-1 b (Fig.  1A)  and  anti-Lm-1 a  (Fig.  IB)  effector  cell  lysis by 
~80% at T:T' ratios _  10:1. This inhibition was Lm-1  specific, since unlabeled 
blasts of the alternative Lm-1  allele did not inhibit lysis. Results similar to those 
of Fig.  1 were also obtained when purified populations of unlabeled splenic T 
and B cells were used to inhibit lysis of splenic T  cell blasts (data not shown). 
In contrast to B cell blasts, the Lm-1 + pre-B  cell lines, SAbl-11  and C.BAbl- 
7853,  failed to inhibit effector cell lysis of thymocyte blasts even at T:T'  ratios 
of 20:1  (data shown for SAbi-11  only) (Fig.  1B). We conclude there is an Lm-1 
determinant common to both T  and B cells that is apparently not expressed on 
LM-1 b-positive pre-B cells. We tentatively designate this determinant Lm-1.1 for 
Lm-1 a strains and Lm-l.11  for Lm-1 b strains. 
A  Common  Lm-1  Determinant  on  Pre-B and  B  Cells  that Is Not Expressed  on  T 
Cells.  Cold-target inhibition experiments were also performed using the Lm-lb 
pre-B cell lines, SAbI-11  and C.BAbl-7853 as the labeled target cells. As shown 
in Fig. 2, B cell blasts were more effective inhibitors of pre-B cell lysis than the 
pre-B cells themselves. This difference is presumably due to a higher density of 
Lm-1  determinants on B cells relative to pre-B cells. Nonetheless, both sources 
of unlabeled targets inhibited lysis (percent  inhibition _>70%  at T:T'  ratios of 
10:1). Thymocyte blasts, on the other hand, were ineffective inhibitors of pre-B 
cell  lysis.  Maximal  inhibition  in  this  case  was <30%.  These  data indicate that 
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FIGURE  l.  Ability of various unlabeled target cells to inhibit effector cell lysis of labeled T 
cells. (A) C.B-26 anti-C.B-31 effector cell lysis of Lm-la-labeled T  cells (where E:T' =  2:1 and 
percent SL =  19) is inhibited by Lm-1"  T  and Lm-1 °  B cells, but not by Lm-1 ~ T  and Lm-1 b B 
cells. (B) C.B-31  anti-C.B-26 effector cell lysis of Lm-1 b cells (where E:T'  =  1:1  and percent 
SL =  20) is inhibited by Lm-I  b T  and Lm-1 n B cells, but not by Lm-1 '~ T  cells and Lm-1 b pre- 
B  cells (SAbI-11).  Lm-I '~  and  Lm-I ~ T  cells were  C.B-31  and  C.B-26  Con  A  SN-activated 
thymocytes; Lm-1 a  and  Lm-1 b  B  cells were  C.B-31  and  C.B-26  LPS-activated  spleen  cells 
depleted of T  cells by passage over nylon wool before activation. O'TOOLE  ET  AL. 
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FIGURE  2.  Ability of various unlabeled target cells to inhibit effector cell lysis of labeled Lm- 
1 n pre-B cell lines. (A) and (B) C.B-31  anti-C.B-26 effector cell lysis of labeled SAbI-11  and 
C.BAbl-7853 pre-B cell lines is inhibited by SAbI-11  (A), C.BAbl-7853 (B), and Lm-1 b B cells, 
but only partially inhibited by Lm-I b T  cells, and not at all by Lm-P  B cells. Lm-1 b T  cells were 
C.B-26 Con A SN-activated thymocytes; Lm-1 a and Lm-1 ~ B cells were C.B-31- and C.B-26- 
activated  spleen  cells  depleted of T  cells  by  passage over  nylon  wool  before activation. 
Conditions: E:T' =  3:1 and percent SL =  17 in A; E:T' =  5:1  and percent SL =  20 in B. 
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FIGURE  3.  Ability of various unlabeled targets to inhibit effector cell lysis of labeled B cells. 
(A) C.B-26 anti-C.B-31  effector cell lysis of Lm-la-labeled B cells (where E:T'  =  0.3:1  and 
percent SL =  35)  is inhibited by Lm-1 °  B cells,  but only partially inhibited by Lm-1 ~ T  cells, 
and not at all by Lm-1 b T  or B cells. (B) C.B-31  anti-C.B-26 effector cell lysis of Lm-P-labeled 
B  cells (where  E:T'  =  0.2:1  and percent SL  =  40)  is inhibited by Lm-1 b  B  cells,  but  not 
appreciably by Lm-1 b T  .  Lm-I b pre-B cells were the C.BAbl-7853 cell line. Lm-P  and Lra-1 b 
T  cells were C.B-31  and C.B-26  Con A  SN-activated thymocytes; Lm-P  and Lm-1 b B cells 
were C.B-31  and C.B-26 LPS-activated spleen cells depleted of T  cells by passage over nylon 
wool before activation. 
there  is  another  Lm-1  determinant, common  to  both  pre-B  and  B  cells,  but 
absent from T  cells,  or poorly expressed on such cells.  This determinant will be 
designated Lm-1.2 for Lm-1 a strains and Lm-1.12 for Lm-1 b strains. 
Inability of Pre-B and T Cells to Inhibit Lysis of B  Cells.  Reciprocal experiments 
to those of Figs.  1 and 2 are shown in Fig. 3.  Here, we compare the ability of 
pre-B cells,  B cell blasts, and thymocyte blasts to inhibit anti-Lm-1 effector cell- 616  Lm-1  EXPRESSION  AND  INCOMPATIBILITY 
mediated lysis of labeled B cell blasts.  The inhibition observed with pre-B cell 
inhibitors was always neglibible, and that observed with thymocytes was usually 
_<15% at T:T' of 20:1. Purified populations of splenic T  cell blasts and SAbl-11 
pre-B  cell  line also failed to inhibit lysis (data not shown). Occasionally, some 
inhibition (20-30%)  was observed when Lm-1 a T  cells were tested as inhibitors 
(Fig.  3A).  The  reason  for  this  is  not  clear,  but  it  might  be  explained  by 
contamination of the B cell target preparations with T  cells. 
Our  interpretation of the  results  in  Fig.  3B  in  light of Figs.  1 and  2  is  as 
follows: Lm-I b B cells express at least two determinants (Lm-1.11 and Lm-1.12), 
one of which is on Lm-1 b T  cells (Lm-l.11), and the other on Lm-1 b pre-B cells 
(Lm-1.12). Therefore, the addition of Lm-I b T  or Lm-1 b pre-B cells alone would 
be  expected  to  inhibit  only one  of two  anti-Lm-1  b effector cell  populations, 
leaving the other population free to lyse B cell targets. 
This interpretation helps explain the apparent differences in  lytic efficiency 
with which anti-Lm-1 effectors lysed B cell blasts, thymocyte blasts and the pre- 
B cell lines. This is indicated by the limiting E:T' ratios for each labeled target 
in the legends of Figs.  1, 2, and 3. As can be noted, B cell blasts were lysed ~ 10 
times more efficiently than  thymocyte blasts,  and  ~25  times more  efficiently 
than pre-B cells  (the mean E:T' ratio for B cell blasts was  0.15:1  vs.  1.5:1  for 
thymocyte blasts, and 4:1  for pre- B cells). 
Effect of Mixtures  of T  and Pre-B Inhibitors  on B  Cell Lysis.  The data in Fig. 3 
leave open  the possibility that  B  cells  may express a  third  Lm-1  determinant 
distinct from both Lm-l.1  (Lm-l.11) and Lm-l.2 (Lm-l.12). We attempted to 
test this by inhibiting B cell lysis with mixtures of T  and pre-B cells. As shown in 
Table V, at T:T' ratios of 10:1 to 20:1, Lm-1 b T  cells or pre-B cells alone gave 
_<16% inhibition (groups B and C), while Lm-1 b B cells gave 78-95% inhibition 
(group A).  Lm-I b pre-B cells mixed with Lm-1 b T  cells,  each at a T:T' of 10:1, 
gave 28%  inhibition (group B). This was only marginally better than the  13% 
inhibition obtained with mixtures of Lm-1 b pre-B cells  and irrelevant Lm-I a T 
cells (group F). At higher T:T' ratios (total T:T' of 40:1), inhibition values in 
the admixture experiments became meaningless, as even irrelevant cells  began 
to inhibit lysis (see group F). 
The relative inability of mixtures of Lm-1 b pre-B and T  cells to inhibit Lm-I b 
B cell  lysis suggests that a  third Lm-1  determinant may be present on B cells. 
This interpretation, however, must be regarded as preliminary. Given two Lm- 
1  b determinants (Lm-l.11 and Lm-l.12) on Lm-I b B cells and two Lm-lb-specific 
CTL populations, there may be cooperative effects in the lysis of Lm-1 b B cells. 
Moreover, possible differences in the density of Lm-1 b determinants on pre-B, 
B, and T  cells could complicate the interpretation of Table V.  Further analysis 
of distinct Lm-1 determinants awaits the availability of Lm-1-specific CTL clones. 
Genetic  Linkage  of Lm-l.1  and  Lm-l.2  (and  Lm-l. ll  and  Lm-l.12)  Determi- 
nants.  The demonstration of distinct Lm-1  determinants suggested that sepa- 
rate genes might code for these determinants and that these might have segre- 
gated in strains known to be chromosomal recombinants in the region near Lm- 
1.  Therefore,  thymocyte and  B  cell  blasts  were  prepared  from  ten  of the 
recombinant strains that were most informative in the previous Lm-i  mapping 
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TABLE  V 
Ability of T and Pre-B Cell Mixtures to Inhibit Anti-Lm-lb Effector 
Cell Lysis of Labeled Lm-1 b B Cells 
Inhibitor 1  Inhibitor 2  Inhibi- 
Group  Final T:T' 
Cell  T:T'  Cell  T:T'  tion 
% 
A  Lm-1 b  5:1  5:1  65 
B Cells  10:l  10:1  78 
20:1  20:1  95 
B  Lm-1 b  5:1  5:1  5 
T  cells*  10:1  10:1  12 
20:1  20:1  16 
C  Lm-1 b  5:1  5:1  6 
Pre-B  10:1  10:1  10 
Cells  20:1  20:1  12 
D  Lm-1 b  5:1  Lm-1 b  5:1  10:1  13 
T  cells*  10:1  Pre-B  10:1  20:1  28 
20:1  20:1  40:1  65 
E  Lrn-1 a  10:1  10:1  2 
T  cells*  20:1  20:1  6 
40:1  40:1  40 
F  Lm-1 a  5:1  Lm-1 b  5:1  10:1  9 
T  cells  10:1  Pre-B  10:1  20:1  13 
20:1  20:1  40:1  48 
E:T' =  0.2:1.  Percent SL was 25%. 
* Con A  SN-activated thymocytes. 
and anti-Lm-1 b effector cells. The data shown in Table VI are representative of 
the results.  No recombinants between the Lm-I ~ and Lm-1 b alleles have, as yet, 
been  found.  Therefore,  if the Lm-1 ~ and Lm-I b loci  were  to contain separate 
genes for Lm- 1.1/Lm- 1.2 and Lm- 1.11/Lm- 1. ! 2, respectively, these genes must 
be closely linked. 
In Vivo Effect of Anti-Lm-1  T  Cells on B  Cells.  Spleen cells from mice immune 
to Lm-l" (or Lm-1 b) were mixed with bone marrow cells from Lm-1 a (or Lm-1 b) 
mice. The mixture was then injected intravenously into X-irradiated recipients 
of the same Lm-1 phenotype as the spleen cell donors. At various time intervals, 
sera  from  the  recipients  were  tested  for  the presence  of allotype of the  bone 
marrow donor.  C.B-26  anti-C.B-31  spleen cells were  the source of anti-Lm-1 a 
cells,  and  BALB/c anti-C.B-17scid  spleen  cells  were  the  source  of anti-Lm-1 b 
cells. The possibility of an anti-Igh  b response was excluded as C.B-17scid  spleen 
cells are surface Ig-negative (11). 
The results were striking, as shown in Table VII. Control recipients (groups 
C,  D,  H,  I,  and J)  showed  Igh-allotype production  by  B  ceils  from  the  bone 
marrow graft within 3-13  wk after cell transfer. Whereas, with one exception, 
no detectable  Igh allotypes of bone  marrow graft origin appeared in this time 
period in experimental groups that received anti-Lm-1  immune ceils (A and E). 
The inhibition was specific for the relevant Lm-1 allele, as demonstrated in group 
F,  where  anti-Lm-1 b immune spleen  cells  did not prevent  production  of Igh  b 
allotype by bone  marrow-derived  Lm-1 a B  cells.  When  unprimed spleen  cells 618  Lm-1  EXPRESSION  AND  INCOMPATIBILITY 
TABLE  VI 
Lm-1 Typing of Thymocyte Blasts  from Recombinant Strains 
SL with:* 
Thymic  Target strain  lgh-c  Tsu  d  Pre-1  Lm-1  Effectors  Splenic  Con A SN 
LPS blasts  blasts 
C.B-31  b  NK*  x  a  a  anti-Lm-1  a  85  26 
anti-Lm-1  b  2  0 
C.B-26  b  NK  ~  o  b  anti-Lm-1  a  4  1 
anti-Lm-1  b  46  19 
AXC-I 1  a  x  +  o  X  a  anti-Lm-P  62  33 
anti-Lm-1  u  0  4 
C.B-AL/1  b  -  ×  a  a  anti-Lm-P  63  17 
anti-Lm-1  b  4  2 
CXAXCB-2  a  -  x  o  x  a  anti-Lm-1  a  83  23 
anti-Lm-  1  b  5  0 
AXC-I l  and  CXAXCB-2 are  the only two strains (out of 46  tested) that have recombinations 
between Pre-I and Lm-1. All recombinant and Lm-1 mapping data is given or cited in reference 1. 
* E:T =  150:1  for both types of effector cells. 
* NK, not known, since both parental strains are Tsu  d. 
TABLE  VII 
Ig Production by CeUs from Bone Marrow Grafts Is Inhibited by Anti-Lm-1 Immune Spleen 
Cells 
Bone mar-  Irradiated 
Group  Spleen cells  row cells  recipients 
Number of recipients showing allo- 
type of bone marrow grafts/number 
tested at weeks after cell transfer: 
3  13  20  30 
A  C.B-26 anti-C.B-31  BALB/c  C.B-17  0/15  0/15  0/15  3/10 
B  C.B-26  BALB/c  C.B-17  1/15  5/15  14/14  10/10 
C  C.B-31  BALB/c  C.B-17  5/10  10/10  10/10  10/10 
D  None  BALB/c  C.B-17  11/15  15/15  15/15  10/10 
E  BALB/c anti-C.B-  C.B-17  BALB/c  1/10  1/10  6/10 
17scid 
F  BALB/c anti-C.B-  C.B-31  BALB/c  9/10  10/10  10/10 
17scid 
G  BALB/c  C.B-17  BALB/c  1/10  10/10  10/10 
H  BALB/c  C.B-31  BALB/c  6/10  8/8  8/8 
I  None  C.B-17  BALB/c  9/10  10/10  10/10 
J  Nolle  C.B-31  BALB/c  9/10  10/10  10/10 
Irradiated recipients were injected with 0.5 ml HBSS containing 10 7 spleen cells and 2 x  10  6 bone 
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were cotransferred with bone marrow cells of a different Lm-1 type, the appear- 
ance of Igh allotype from the bone marrow graft was delayed (Table VII, groups 
B and G compared to C and H). 
7  mo  after  cell  transfer,  Igh allotype production by donor bone  marrow- 
derived  cells  was  observed  in  some  recipients  (Table  VII,  groups A  and  E) 
indicating that successful engraftment of bone marrow cells occurred in at least 
some  (if not  all)  recipients.  The  implications  of this  are  considered  in  the 
Discussion. 
Discussion 
Expression of Distinct Lm-1 Determinants on Different Cell Types.  We have shown 
that antigenic determinants encoded by the Lm-i  locus are expressed on B and 
T  cell blasts, some pre-B cell lines, and macrophages. That expression of these 
determinants is  dependent on  the stage of cell  differentiation or state of cell 
activation  is  inferred  from  the  following:  First,  Lm-1  determinants  are  not 
detected on fibroblasts (Table IV).  Lm-1  is not, therefore, a constitutive mem- 
brane protein of all cells.  Also, we have found immature B and T  cell lines that 
do not express Lm-1 determinants (Tables II and III). Unstimulated thymocytes 
also do not express Lm-1 determinants, whereas thymocyte blasts and splenic T 
cell blasts are Lm-1 + (Table I). These results indicate that Lm-1 is a differentiation 
antigen that is expressed by lymphoid cells as they mature. 
We have shown that distinct Lm-1  determinants are differentially expressed 
on T, pre-B, and B cells.  Two Lm-1 determinants were defined on the basis  of 
cold-target inhibition assays. These were designated Lm-1.1 and Lm-l.2 for Lm- 
I a mouse strains and  Lm-l.ll  and  Lm-l.12  for Lm-1 b mouse strains.  Lm-1 b- 
expressing T, pre-B, and B cells typed Lm- 1.11 +/Lm-  1.12-, Lm- 1.11 -/Lm- 1.12 +, 
and Lm- 1.11 +/Lm- 1.12 +, respectively. Similarly, Lm- l"-expressing T  and B cells 
typed Lm-l.l+/Lm-l.2  -  and  Lm-l.l+/Lm-l.2  +,  respectively.  Lm-1 a pre-B  cell 
lines  from  the  Lm-I ~ congenic  strains,  BALB/cAnNIcr or  C.B-31,  were  not 
available,  but  presumably  express  only  Lm-l.2.  Evidence  for  a  third  Lm-1 
determinant on  B cells was presented (Table  V),  but  confirmation awaits the 
availability of Lm-1-specific T  cell clones. 
Whether a  given determinant is detected may depend on the immunization 
protocol used to generate effector T  cells. For example, with our protocol, which 
included the use of adjuvant, mice had to be immunized at least four times to 
obtain effector cells that lysed macrophages, whereas two immunizations were 
sufficient to  generate effector cells that  lysed T,  B,  and pre-B  cells  (data not 
shown).  Since  the  increased  number  of immunizations did  not  increase  the 
number or efficiency of CTL specific for lymphocytes, these data suggest that 
macrophages may express an additional Lm-1 determinant. 
The  Lm-1  Locus  and  its  Relationship  to  Other  Igh-linked  Alloantigens.  The 
finding that  different immunization protocols  may result  in  the  detection of 
distinct determinants suggests an explanation for reported differences on  the 
cell distribution of Igh-linked  alloantigens detected by CTL. As mentioned in 
the introduction, two other reported (2, 3) cell-surface antigens, H-40 and H(CH), 
are encoded by genes on chromosome 12, telomeric to Igh. Like Lm-1, both are 
defined as a target antigen in a CTL assay. Their map position relative to Lm-I 620  Lm-I  EXPRESSION  AND  INCOMPATIBILITY 
and/or  Pre-I  has  not  yet  been  determined.  However,  given  our  preliminary 
evidence (Table V) for a third Lm-1 determinant on B cells, it is possible that H- 
40 (2) is a B cell-specific member of the Lm-1 family of determinants.  Similarly, 
H(C,) (3),  which  is expressed on both  B and  T  cell blasts,  may correspond  to 
Lm-l.1. Lm-1, H-40,  and H(C~) may all be members of a genetic complex that 
codes for a family of lymphoid and macrophage differentiation antigens. Forman 
et al.  (2) have found that  H-40 expression accompanies surface Ig expression, 
and have suggested therefore that  H-40 is important  in B cell function.  Given 
our data on the complexity of the Lm-1 antigen system, the pattern of expression 
of these antigens  and  their  modulation  during  lymphocyte activation,  it seems 
likely  that  the  Lm-1  locus  is  important  for  the  function  and  interaction  of 
lymphocytes and macrophages. 
In addition to H-40 and H(CH), there is another cell surface antigen encoded 
on the telomeric portion of chromosome 12 that could also be a member of the 
Lm-1  family of antigens.  The  gene  for the chemically induced,  tumor-specific 
transplantation  antigen,  Meth A, has been mapped to the teiomeric portion  of 
chromosome  12  (16),  probably  telomeric  to  Pre-1 (see  ref.  1).  Biochemical 
analyses of different methylcholanthrene-induced,  tumor-specific transplantation 
antigens  has led DuBois et al.  (17) to propose that  the Meth A  antigen  itself is 
the product of a  member of a  multigene family. In independent  studies,  Flood 
et al. (18) reported evidence that the Meth A antigen is serologically crossreactive 
with T  cell-derived factors. This suggests that  the normal  homologue of Meth 
A is involved in lymphocyte function. These data strengthen our hypothesis that 
the telomeric end of chromosome  12 codes for a family of cell surface antigens 
that  play a  role in  the differentiation  and  function of lymphocytes and  macro- 
phages. 
Lm-1  is similar in  many ways to the T-200  family of antigens  (19-31).  Cell- 
specific antigenic  determinants  of the T-200 family have been identified for T 
cells,  B  cells,  and  macrophages  (25-27).  Thus,  T-200  shares  with  Lm-1  the 
characteristics  of lymphocyte-macrophage specificity (22),  regulated expression 
during  differentiation  (28),  and  differential  expression  of  distinct  antigenic 
determinants (25-27). These characteristics have made the T-200 antigen system 
of interest to many who study hemopoiesis, lymphocyte differentiation, and the 
function of cell-specific membrane molecules (25-30). 
Despite  their  similarities,  Lm-1  and  T-200  can  be distinguished  on  genetic 
grounds.  Lm-1  is coded by one or more genes on chromosome  12 (1),  whereas 
Ly-5, an antigenic determinant  common to all members of the T-200 family, is 
coded by a  gene on chromosome  1 (23,  24,  31).  Lm-1, therefore, represents a 
newly  identified  antigen  system  whose  potential  usefulness  to  the  study  of 
lymphoid and myeloid differentiation resembles that of T-200. 
The molecular basis for distinct  Lm-1  (or T-200) determinants  is not under- 
stood. Different Lm-1  determinants  might result from cell-specific modification 
of one or more Lm-1  polypeptides before insertion  into the membrane.  Prece- 
dent  for  this  idea  comes  from  a  number  of systems.  Thy-1  molecules  show 
differences between  cell  types due  to  posttranslational  modification  (32),  and 
differences in  function between Ia molecules on B cells and macrophages have 
been associated with  carbohydrate  moieties (33).  Also, evidence that  the  same O'TOOLE  ET  AL.  621 
T-200  molecule can  display different antigenic  determinants  (26) is consistent 
with  this  idea.  Each  Lm-1  determinant,  on  the other hand,  could represent  a 
separate gene product in the form of a single polypeptide or heteropolymer on 
the cell surface.  Such Lm-I  genes would have to be closely-linked (Table  VI), 
and presumably would be structurally and functionally related. 
Effects  of Lm-l-incompatibility on B Lymphocyte Function.  Cell transfer experi- 
ments showed that anti-Lm-1  T  cells (presumably CTL) can prevent Igh allotype 
production in vivo. Injection of X-irradiated Lm-lb recipients with bone marrow 
cells from Lm-1 ~ mice together with anti-Lm-l"-specific spleen ceils resulted  in 
inhibition of Igh  a allotype production of the bone marrow-derived donor B ceils. 
Similar  results were obtained in  the reciprocal experiment.  The  bone marrow 
grafts were apparently  not rejected, as is evident from the appearance  of Igh  a 
(or lgh b) allotype in some recipients  7  mo after cell transfer.  To explain  these 
results we reason as follows: X-irradiated recipients were engrafted with Lm-1- 
stem cells from the bone marrow graft (that such cells exist is inferred from our 
detection  of Lm-1-  A-MuLV  pre-B cell  lines).  As progeny of these stem  cells 
matured and expressed Lm-1  determinants,  they were killed (or suppressed) by 
anti-Lm-1  effector cells. However, with the presumed death of donor anti-Lm-1 
effector cells 5-7 mo after cell transfer, some bone marrow stem cells were able 
to differentiate  into  Lm-1 ÷,  Igh-producing  B  cells.  Their ability to do so may 
have depended  on  whether  the host had  become tolerant  or immune  to cells 
expressing the foreign Lm-1  determinants. 
Although  we  did  not  test  the  above recipients  for  Lm-l-expressing  macro- 
phages and T  cells of donor bone marrow origin, it seems likely that differentia- 
tion and maturation of these cell types may also have been prevented or inhibited. 
Finally, the implications of Lm-l-incompatibility are worth noting.  Incompat- 
ibility at  the Lm-1  locus could help explain  the previously observed Igh-linked 
restriction  in T-B and T-T  cell-cell interactions  (34-40).  For example,  reports 
that the induction (34, 35) or activity (37) ofT cell-suppressor factors is restricted 
by Igh-linked  genes may in  fact reflect a  restriction  imposed by Lm-1 or other 
closely-linked loci.  Further,  the  lack of synergy observed by L'Age-Stehr  (38) 
between T  and B cells of C.B-17 and BALB/c mice may have been due to anti- 
Lm-l-specific T  cell aggression against B cells. Second, relevant to bone marrow 
transplantation  in  general,  incompatibility  at Lm-1  and  its human  counterpart 
could  contribute  to  graft-vs.-host  disease,  and/or  could  severely  impair  the 
growth and differentiation of engrafted stem cells. 
Summary 
Lm-1  is  an  Igh-linked  locus  that  codes  for  cell  surface  alloantigens  (Lm-1 
determinants)  recognized by T  lymphocytes.  Using Lm-1  congenic strains  and 
cold-target inhibition  of anti-Lm-l-specific lysis by cytotoxic T  lymphocytes, we 
were able to demonstrate differential expression of two distinct Lm-1  antigenic 
determinants.  One determinant  is expressed on the surface of T  cell blasts, the 
other on a  number of pre-B cell lines.  Both determinants  are present on B cell 
blasts. Macrophages also bear Lm-1  determinants,  and possibly express a deter- 
minant  not found on  lympbocytes. Fibroblasts, (unstimulated)  thymocytes, and 
immature  T  cells lack detectable Lm-1  determinants.  These data indicate that 622  Lm-1 EXPRESSION  AND  INCOMPATIBILITY 
expression of the Lm-I  locus is dependent  on cell lineage and  the  stage of cell 
differentiation or activation. We propose that Lm-i is a lymphocyte-macrophage 
differentiation locus containing a number of structurally and functionally related 
genes. 
Evidence was presented that Lm-I may also serve as a  histocompatibility locus 
of major importance for bone marrow transplantation.  Specifically, when Lm-1- 
incompatible  bone  marrow  cells  and  spleen  cells  (from  normal  or  anti-Lm-1 
immune  mice)  were  transplanted  into  X-irradiated  recipients,  the  maturation 
and/or function of bone marrow-derived donor B cells was delayed or inhibited. 
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criticism, E. Cunningham,  D. Williams, and C. Standers for technical assistance, and L. 
Bartasavich, H. McGinley, and G. Zygmunt for typing this manuscript. 
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